Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22

Journal of Neuroscience

Volumn 20, Issue 11, 2000, Pages 4120-4128

  Niemann, Stephan ^a   Sereda, Michael W ^a,d   Suter, Ueli ^b   Griffiths, Ian R ^c   Nave, Klaus Armin ^a,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Abnormal gene dosage; Axon Schwann cell interaction; Charcot Marie Tooth neuropathy; Myelin disease; Myelin protein function; Transgenic disease model

Indexed keywords

MYELIN PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE MUTATION; GENE OVEREXPRESSION; GOLGI COMPLEX; MYELIN SHEATH; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN TRANSPORT; RAT; SCHWANN CELL;

EID: 0034212644     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-11-04120.2000     Document Type: Article

References (66)

1. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U (1995) Hypermyelination and demyelinating peripheral neuropathy in PMP-22-deficient mice. Nat Genet 11:274-280.
2. Adlkofer K, Frei R, Neuberg DH, Zielasek J, Toyka KV, Suter U (1997a) Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 17:4662-4671.
3. Adlkofer K, Naef R, Suter U (1997b) Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele. J Neurosci Res 49:671-680.
4. Anzini P, Neuberg DH, Schachner M, Nelles E, Willecke K, Zielasek J, Toyka KV, Suter U, Martini R (1997) Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J Neurosci 17:4545-4551.
5. Archelos JJ, Roggenbuck K, Schneider-Schaulies J, Linington C, Toyka KV, Hartung HP (1993) Production and characterization of monoclonal antibodies to the extracellular domain of P0. J Neurosci Res 35:46-53.
6. Baechner D, Liehr T, Hameister H, Altenberger H, Grehl H, Suter U, Rautenstrauss B (1995) Widespread expression of the peripheral myelin protein-22 gene (PMP22) in the neural and non-neural tissues during murine development. J Neurosci Res 42:735-741.
7. Bermingham JR, Scherer SS, O'Connell S, Arroyo E, Kalla KA, Powell FL, Rosenteld MG (1996) Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev 10:1751-1762.
8. Brancolini C, Marzinotto S, Edomi P, Agostini H, Fiorentini C, Müller HW, Scheider C (1999) Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol Biol Cell 10:2441-2459.
9. Chavrier P, Zerial M, Lemaire P, Almendral J, Bravo R, Charnay P (1988) A gene encoding a protein with zinc fingers is activated during G(0)/G(1) transition in cultured cells. EMBO J 7:29-35.
10. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
11. Coetzec T, Suzuki K, Popko B (1998) New perspectives on the function of myelin galactolipids. Trends Neurosci 21:126-130.
12. D'Urso D, Prior R, Greiner-Petter R, Gabreels-Festen AA, Müller HW (1998) Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J Neurosci 18:731-740.
13. de Wulf P, Bernhardt RR, Suter U (1999) Characterization of peripheral myelin protein 22 in zebrafish (zPMP22) suggests an early role in the development of the peripheral nervous system. J Neurosci Res 57:467-478.
14. Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (1993) Peripheral Neuropathy, Vol 2. Philadelphia: Saunders.
15. Fabbretti E, Edomi P, Brancolini C, Schneider C (1995) Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev 9:1846-1856.
16. Friede RL, Samorajski T (1968) Myelin formation in the sciatic nerve of the rat: a quantitative electron microscopic, histochemical and autoradiographic study. J Neuropath Exp Neurol 27:546-570.
17. Giese KP, Martini R. Lemke G, Soriano P, Schachner M (1992) Disruption of the P0 gene in mice leads to abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71:565-576.
18. Gow A, Friedrich VL, Lazzarini RA (1994) Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J Neurosci Res 37:574-583.
19. Hagedorn L, Suter U, Sommer L (1999) P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. Development 126:3781-3794.
20. Hanemann CO, Müller HW (1998) Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy. Trends Neurosci 21:282-286.
21. Hanemann CO, Gabreels-Festen AA, Müller HW, Stoll G (1996) Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages. Brain 119:1461-1469.
22. Huxley C, Passage E, Manson A, Putzu G, Figarella-Branger D, Pellissier JF, Fontes M (1996) Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5:563-569.
23. Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Saberan-Djoniedi D, Figarella-Branger D, Pellissier JF, Thomas PK, Fontes M (1998) Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 7:449-458.
24. Ionasescu VV, Searby CC, Ionasescu R, Chatkupt S, Patel N, Koenigsberger R (1997) Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. Muscle Nerve 20:97-99.
25. Jaegle M, Mandermakers W, Broos L, Zwart R, Karis A, Visser P, Grosveld F, Meijer D (1996) The POU factor Oct-6 and Schwann cell differentiation. Science 273:507-510.
26. Jung M, Sommer I, Schachner M, Nave K-A (1996) Monoclonal antibody O10 defines a conformationally sensitive cell-surface cpitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci 16:7920-7929.
27. Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631-664.
28. Lemke G, Axel R (1985) Isolation and sequence of a cDNA encoding the major structural protein of peripheral myclin. Cell 40:501-508.
29. Lemke G, Chao M (1988) Axons regulate SC expression of the major myelin and NGF receptor genes. Development 102:499-504.
30. Lupski JR, de Oca Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219-232.
31. Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembie Z, Zielasek J, Toyka KV, Suter U (1996) Impaired differentiation of SCs in transgenic mice with increased PMP22 gene dosage. J Neurosci 16:5351-5360.
32. Manfioletti G, Ruaro ME, Del Sal G, Philipson L, Schneider C (1990) A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol 10:2924-2930.
33. Martini R, Schachner M (1997) Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules. Glia 19:298-310.
34. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M (1995) Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathic. Nat Genet 11:281-286.
35. Mirsky R, Jessen KR (1996) Schwann cell development, differentiation and myelination. Curr Opin Neurobiol 6:89-96.
36. Monuki ES, Weinmaster G, Kuhn R, Lemke G (1989) SCIP: a glial cell POU domain gene regulated by cyclic AMP. Neuron 3:783-793.
37. Monuki ES, Kuhn R, Weinmaster G, Trapp BD, Lemke G (1990) Expression and activity of the POU transcription factor SCIP. Science 249:1300-1303.
38. Naef R, Suter U (1998) Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc Res Tech 41:359-371.
39. Naef R, Suter U (1999) Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol Disease 6:1-14.
40. Naef R, Adlkofer K, Lescher B, Suter U (1997) Aberrant protein trafficking in trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol Cell Neurosci 9:13-25.
41. Nave K-A (1995) Neurological mouse mutants: a molecular genetic analysis of myelin proteins. In: Neuroglial cells (Kettenmann H, and Ransom B, eds), pp 571-586. New York: Oxford UP.
42. Notterpek L, Shooter EM, Snipes GJ (1997) Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy. J Neurosci 17:4190-4200.
43. Parmantier E, Cabon F, Braun C, D'Urso D, Mueller HW, Zalc B (1995) Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons. Eur J Neurosci 7:1080-1088.
44. Patel PI, Roa B, Welcher AA, Schoener-Scott R, Trask B, Pentao L, Snipes GJ, Garcia CA, Francke U, Shooter EM, Lupski JR, Suter U (1992) The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1:159-165.
45. Radeke MJ, Misko TP, Hsu C, Herzenberg LA, Shooter EM (1987) Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 325:593-597.
46. Roa BB, Dyck PJ, Marks HG, Chance PF, Lupski JR (1993) Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 5:269-273.
47. Roach A, Boylan KB, Horvath S, Prusiner SB, Hood LE (1983) Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell 34:799-806.
48. Sancho S, Magyar JP, Aguzzi A, Suter U (1999) Distal axonopathy in peripheral nerves of PMP22 mutant mice. Brain 122:1563-1577.
49. Sereda M, Griffiths I, Pühlhofer A, Stewart H, Rossner MJ, Zimmermann F, Magyar JP, Schneider A, Hund E, Meinck H-M, Suter U, Nave K-A (1996) A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16:1049-1060.
50. Snipes GJ, Suter U (1995) Molecular basis of common hereditary motor and sensory neuropathies in humans and in mouse models. Brain Pathol 5:233-247.
51. Snipes GJ, Suter U, Welcher AA, Shooter EM (1992) Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 117:225-238.
52. Sommer L, Suter U (1998) The glycoprotein P0 in early peripheral gliogenesis. Cell Tissue Res 292:11-16.
53. Spreyer P, Kuhn G, Hanemann CO, Gillen C, Schaal H, Kuhn R, Lemke G, Muller HW (1991) Axon-regulated expression of a Schwann cell transcript that is homologous to a "growth arrest-specific" gene. EMBO J 10:3661-3668.
54. Stoffel W, Bosio A (1997) Myelin glycolipids and their functions. Curr Opin Neurobiol 7:654-661.
55. Suter U, Moskow JJ, Welcher AA, Snipes GJ, Kosaras B, Sidman RL, Buchberg AM, Shooter EM (1992a) A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci USA 89:4382-4386.
56. Suter U, Welcher AA, Ozcelik T, Snipes GJ, Kosaras B, Francke U, Billings-Gagliardi S, Sidman RL, Shooter EM (1992b) Trembler mouse carries a point mutation in a myelin gene. Nature 356:241-244.
57. Tobler A, Notterpek L, Naef R, Taylor R, Suter U, Shooter EM (1999) Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction. J Neurosci 19:2027-2036.
58. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi ABY, Seitanidou T, Babinet C, Charnay P (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371:796-799.
59. Tso JY, Sun XH, Kao TH, Reece KS, Wu R (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNA: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502.
60. Valentijn LJ, Baas F, Wolterman RA, Hoogendijk JE, van den Bosch NH, Zorn I, Gabreels-Festen AW, de Visser M, Bolhuis PA (1992) Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 2:288-291.
61. Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob KG, Lupski JR (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 4:382-384.
62. Webster H (1993) Development of peripheral nerve fibres In: Peripheral neuropathy. Ed 3 (Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds), pp 243-266. Philadelphia: Saunders.
63. Welcher AA, Suter U, De Leon M, Snipes GJ, Shooter EM (1991) A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc Natl Acad Sci USA 88:7195-7199.
64. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Müller HW (1995) Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in SCs: modulation of cell growth. EMBO J 14:1122-1128.
65. Zorick TS, Lemke G (1996) SC differentiation. Curr Opin Cell Biol 8:870-876.
66. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G (1996) The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in SC differentiation. Mol Cell Neurosci 8:129-145.